TSS:Hg 219838.1

Basic information about the TSS

---

TSS ID: hg_219838.1 Species: human Chr: chr9		Start: 99128027 End: 99128028 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000546584.1 Distance: -94 GeneID: 7046 HGNC/MGI_ID: HGNC:11772 UniProt_ID: H0YHS4

Gene_name: transforming growth factor beta receptor 1 Gene_symbol: TGFBR1 Gene_synonyms: ACVRLK4 ALK-5 ALK5 TBR-i TBRI Gene_source: HGNC:11772

TATA-Box annotation

---

Distance to TSS:	22915
Nearest PromoterID:	NM_004612
Entrez ID:	7046
Nearest Unigene:	Hs.494622
Nearest Refseq:	NM_004612
Nearest Ensembl:	ENSG00000106799
Gene Name:	transforming growth factor beta receptor 1
Gene Alias:	AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TBR-i|TBRI|TGFR-1|tbetaR-I
Gene Description:	transforming growth factor beta receptor 1
Gene Type:	protein-coding
CpG%:	0
GC%:	0.40796
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TGFBR1 p2@TGFBR1 p3@TGFBR1 p4@TGFBR1 p5@TGFBR1 p6@TGFBR1
Sample		p1@TGFBR1	p2@TGFBR1	p3@TGFBR1	p4@TGFBR1	p5@TGFBR1	p6@TGFBR1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.16	2.53	0.78	0.19	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.09	2.23	1.01	0.61	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	10.22	2.12	0.96	0.19	0.58	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	10.40	2.91	0.21	0.62	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.42	1.57	1.35	0.22	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.50	1.16	0.39	0.19	0.78	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	8.50	3.05	0.87	0.00	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.93	0.73	0.48	0.00	0.97	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.26	2.14	0.43	0.00	0.85	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	9.27	2.32	0.58	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.11	2.02	0.81	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.79	2.03	1.63	0.00	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	11.77	2.74	0.48	1.29	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.13	2.26	0.45	0.15	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.64	1.98	1.76	0.88	1.10	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.04	3.52	0.50	0.50	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.12	1.97	0.44	0.66	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.06	3.37	1.69	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	3.20	2.13	0.53	1.07	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.18	2.26	0.90	0.45	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	9.36	2.27	0.27	0.80	0.80	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.84	1.73	1.04	0.00	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.27	2.59	1.16	0.78	0.52	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.46	2.43	1.21	0.49	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.55	3.61	0.77	1.03	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	7.60	2.53	0.95	0.32	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.89	6.04	1.10	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.32	3.06	1.18	1.18	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.44	1.78	1.62	0.81	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.67	2.17	1.63	0.18	0.72	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.33	3.35	0.21	0.84	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.57	2.54	0.98	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	5.91	4.43	0.42	0.63	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.40	2.97	0.99	0.16	0.66	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.72	2.62	1.68	0.56	0.93	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.54	3.45	0.77	0.57	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.63	1.64	0.41	0.82	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.05	1.61	0.40	0.60	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	9.99	1.89	1.62	0.00	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.28	2.40	1.44	0.96	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.65	2.82	0.71	0.00	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.91	2.05	0.44	0.29	0.73	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.97	2.11	0.84	0.63	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.57	1.75	1.05	1.22	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.85	2.41	0.80	0.40	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	11.17	2.33	0.23	0.00	0.70	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.08	3.12	1.44	0.24	0.72	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.75	2.38	0.30	0.60	1.19	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.01	2.63	1.44	0.24	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.11	2.02	1.21	0.20	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	5.53	3.28	1.23	0.61	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	8.67	3.56	0.89	1.56	1.56	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	41.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.52	5.68	1.06	1.77	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.28	1.99	2.65	2.32	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	15.94	0.00	0.00	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.97	3.21	2.76	0.92	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.48	2.92	0.65	3.24	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	6.42	5.14	0.96	2.57	0.96	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.40	3.14	0.31	0.94	2.51	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3.53	2.12	0.71	2.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.05	2.24	1.12	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	10.35	3.18	0.80	8.76	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	3.06	3.74	0.68	0.68	1.70	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.87	6.82	0.65	4.55	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.26	3.55	0.71	1.42	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	48.49	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	63.18	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.85	2.44	0.00	0.98	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	7.93	3.97	1.98	1.49	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.10	1.88	0.94	2.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.31	2.65	0.99	1.32	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.95	4.33	0.31	1.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5.50	1.53	0.92	1.22	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	11.72	5.07	1.43	1.11	0.32	0.48
Adipocyte - breast, donor2	11327-117E4	14.28	7.38	1.12	0.32	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	15.52	6.49	1.40	1.53	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	22.42	4.48	0.75	0.75	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	20.76	3.68	1.00	0.00	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	13.40	8.29	0.64	0.64	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	2.20	2.20	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.52	1.35	0.00	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	9.38	2.09	0.35	0.87	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	37.55	12.32	1.17	1.76	0.39	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	48.64	11.84	3.35	8.24	3.35	1.80
Adipocyte differentiation, day04, donor3	13025-139E1	15.05	5.02	2.23	1.12	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	12.93	1.18	0.59	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.18	2.98	1.29	0.40	0.16	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	15.17	5.16	0.65	2.58	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	2.67	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	7.23	3.90	0.56	1.11	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	19.96	1.25	0.00	0.83	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	14.82	5.53	0.75	1.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	1.64	0.65	0.33	0.98	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	9.74	2.74	0.00	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	13.26	3.98	0.88	0.44	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	1.08	0.72	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	32.02	7.20	1.80	0.72	1.26	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	15.06	3.35	0.00	0.00	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	21.78	5.75	1.64	2.26	1.03	0.82
Anulus Pulposus Cell, donor1	11248-116E6	5.84	1.03	1.14	0.00	0.46	0.11
Anulus Pulposus Cell, donor2	11463-119B5	11.02	0.98	0.98	0.00	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.19	6.29	0.45	0.90	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	5.21	0.87	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	0.00	2.14	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.17	6.28	0.30	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	7.59	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.28	3.96	0.66	1.32	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.80	6.17	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	4.85	0.49	0.00	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	4.75	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.90	5.65	0.38	0.38	1.13	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	0.00	0.00	2.18	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	5.02	1.25	0.00	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5.27	2.14	0.82	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	4.09	0.00	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.09	4.67	0.75	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	5.36	0.00	0.54	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.88	6.23	0.76	0.38	0.94	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.75	5.61	0.80	0.27	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	9.75	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.62	6.14	0.66	0.66	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4.80	3.60	1.20	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.78	5.32	1.03	0.34	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.85	8.25	0.97	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	4.55	0.76	0.38	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	6.06	1.21	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	7.41	0.57	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.70	7.91	1.50	0.64	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.90	4.13	0.52	0.77	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.10	4.69	0.47	0.00	0.94	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.32	6.11	0.32	0.64	1.93	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	4.99	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	4.09	0.58	1.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.13	6.92	1.20	0.60	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	2.38	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	3.05	5.09	0.51	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.84	4.58	1.02	1.53	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.81	3.81	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	3.88	1.29	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.20	5.72	1.06	0.21	0.85	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	7.54	0.87	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	0.94	5.67	0.94	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.46	5.76	0.85	0.85	1.19	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	6.95	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.15	7.08	0.21	0.64	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	9.63	0.00	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	8.02	0.00	0.00	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.51	3.22	0.23	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.08	4.32	0.25	0.25	1.27	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.43	7.23	1.45	0.83	1.03	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.59	4.90	0.31	0.92	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.52	5.26	0.96	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.10	5.77	0.44	0.89	0.89	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	4.58	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	6.09	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.94	5.30	0.26	0.53	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.45	6.54	0.36	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	9.58	0.00	0.61	0.37	0.12	0.12
Astrocyte - cerebellum, donor2	11580-120F5	11.13	0.00	0.51	0.34	0.51	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.03	0.84	0.21	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	34.16	9.06	2.79	0.00	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	22.65	9.87	1.78	0.81	1.29	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	40.72	7.91	2.83	2.24	2.39	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	10.55	2.87	1.95	0.46	0.34	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	10.15	4.26	2.38	0.25	0.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	9.79	1.93	2.50	0.11	0.11	0.34
Basophils, donor1	12241-129G9	21.18	0.00	0.78	0.26	0.26	0.00
Basophils, donor2	12242-129H1	29.22	2.53	0.72	0.72	0.36	0.72
Basophils, donor3	12243-129H2	27.34	3.53	0.88	0.29	0.73	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	5.61	1.08	0.00	0.00	0.22	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	0.91	0.91	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	5.02	0.63	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	16.84	2.29	1.25	0.83	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	6.22	2.30	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	19.43	5.40	1.08	0.90	1.62	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	16.28	5.98	1.96	0.21	0.82	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	17.00	9.32	3.49	0.70	0.70	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	15.35	2.88	2.88	0.64	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	17.47	3.38	1.69	0.00	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	17.82	7.80	1.48	0.19	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	16.90	4.17	1.10	0.66	0.22	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	52.93	3.40	4.81	1.70	0.28	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	59.89	13.27	8.72	2.27	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.36	11.18	8.55	4.60	1.64	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	72.85	45.53	5.49	2.60	1.73	1.73
CD14+ monocytes - mock treated, donor2	11873-125C1	91.73	28.36	8.75	10.26	1.51	2.41
CD14+ monocytes - mock treated, donor3	11883-125D2	86.70	35.77	4.50	13.27	4.03	4.03
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	43.52	39.00	3.35	5.19	1.67	2.68
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	70.66	31.74	4.97	14.08	2.76	5.52
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	69.92	22.07	5.45	5.70	1.74	2.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	16.84	9.79	1.37	0.98	0.59	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	23.50	7.83	1.78	2.14	1.07	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	21.98	4.13	1.31	0.65	0.65	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.48	12.88	2.34	2.58	0.94	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	33.27	8.98	3.70	5.81	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	49.92	9.98	3.33	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	51.47	30.64	2.08	3.57	2.68	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	58.27	17.96	2.39	5.19	0.40	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	53.30	10.20	4.37	3.75	2.91	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	25.40	15.10	1.60	1.37	0.69	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	33.93	3.62	1.81	2.26	0.45	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	29.24	10.48	0.87	2.18	1.75	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	26.09	14.53	2.69	0.54	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	34.19	17.62	2.62	4.19	1.40	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	45.03	7.15	2.95	3.37	2.10	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.78	8.63	1.47	0.73	0.73	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	19.37	3.87	1.41	2.11	0.35	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	16.23	7.90	1.75	1.75	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	26.68	19.70	2.62	1.92	1.22	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	21.93	17.10	1.12	4.09	1.12	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	30.18	3.45	1.94	0.43	0.65	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	10.24	8.19	2.46	1.64	0.82	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	18.31	1.62	0.93	0.23	0.70	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.38	2.78	1.62	1.16	0.93	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	10.24	1.53	0.22	0.00	0.65	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	7.62	0.46	1.15	0.46	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	5.63	1.95	0.00	0.43	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	14.95	0.93	0.93	0.62	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	10.48	2.45	1.22	0.17	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	18.06	0.45	1.11	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	7.40	0.77	0.26	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	6.15	1.32	0.22	0.22	0.00	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	6.11	1.05	0.42	0.42	0.21	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.27	2.71	0.68	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	2.07	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	24.52	1.60	1.07	0.53	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.94	0.00	1.07	0.00	1.61	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	2.11	0.00	1.40	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	14.12	3.92	1.57	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	7.91	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	11.51	9.86	1.64	4.11	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	15.96	5.08	0.73	0.73	0.73	2.90
CD19+ B Cells, donor3	11705-123B4	22.72	9.09	0.50	2.02	3.03	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	6.06	0.40	0.40	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	6.79	1.60	0.40	0.40	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	12.05	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	32.02	2.25	1.69	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	16.16	4.51	1.13	0.00	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	10.82	1.58	1.35	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	13.21	1.79	1.79	0.36	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	12.25	6.74	0.61	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	11.59	5.79	0.61	1.22	0.91	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	62.79	10.46	5.62	1.79	1.53	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	59.97	20.44	4.72	2.25	4.72	2.47
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	57.78	12.65	6.90	2.87	2.87	4.02
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.59	0.95	1.42	0.00	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	15.45	3.51	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	0.00	3.30	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	16.91	4.77	2.46	0.14	1.01	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	46.60	27.62	2.88	3.90	3.22	2.20
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	40.14	19.99	2.90	4.03	3.22	2.42
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	9.41	3.59	0.45	0.45	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	10.83	1.75	1.40	0.00	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	9.68	1.32	1.32	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.03	9.70	3.37	2.11	2.11	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	24.93	20.78	1.87	2.08	1.66	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	25.06	14.70	2.67	2.00	1.67	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	7.34	3.26	0.54	0.27	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	10.72	2.14	1.07	1.07	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	3.59	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	35.60	9.64	4.82	0.56	1.30	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.09	6.28	1.73	1.30	0.65	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	39.93	6.51	4.41	1.68	1.26	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	12.13	2.02	2.53	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.96	0.43	0.43	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	15.25	0.44	0.87	0.44	0.87	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	37.12	6.43	2.97	0.49	1.48	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	45.24	5.54	2.77	0.00	0.00	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	29.31	6.98	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	51.23	0.55	4.43	0.83	0.83	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	51.78	0.49	3.93	0.49	0.98	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	33.88	3.08	3.08	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	43.69	5.73	5.01	0.36	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	51.24	15.23	5.54	2.77	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	20.95	7.86	1.31	2.29	0.65	1.31
CD8+ T Cells, donor2	11307-117C2	24.78	20.27	1.13	0.75	1.13	0.75
CD8+ T Cells, donor3	11383-118B6	23.99	9.59	0.76	1.77	2.52	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.88	2.52	0.92	0.00	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.27	2.40	0.48	0.24	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.47	1.09	1.64	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.60	1.80	1.50	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.44	1.92	1.20	0.48	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	9.10	2.73	1.36	0.00	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.95	3.04	2.61	0.43	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.47	1.58	1.58	0.79	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	8.91	2.58	0.47	0.23	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	11.17	2.72	2.42	0.30	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.59	1.74	1.16	0.29	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.66	1.07	2.13	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.69	5.25	2.19	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.12	5.47	1.37	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	5.97	0.75	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.80	3.24	1.08	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.92	0.86	1.15	0.29	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.72	3.06	0.94	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.04	2.22	1.27	0.63	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.92	1.23	1.23	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9.30	1.60	1.28	0.32	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.18	3.06	1.53	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.46	2.76	1.58	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	1.51	0.00	1.51	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.04	1.61	0.80	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	14.69	4.90	2.10	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	14.02	2.00	4.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	3.66	0.00	1.83	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	3.46	0.99	0.00	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	16.42	2.84	1.47	0.42	0.42	0.21
Chondrocyte - de diff, donor1	11261-116G1	48.53	32.59	1.39	2.77	2.08	2.77
Chondrocyte - de diff, donor2	11338-117F6	29.50	4.62	3.20	0.71	0.71	1.07
Chondrocyte - de diff, donor3	11410-118E6	42.10	27.42	3.07	3.64	2.62	1.59
Chondrocyte - re diff, donor2	11339-117F7	41.18	0.90	1.79	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	26.29	4.85	2.02	1.21	1.62	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	21.69	4.36	2.30	0.46	1.03	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	17.96	7.91	1.71	0.64	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	17.35	3.89	1.68	0.71	1.42	1.24
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	19.35	2.84	3.03	0.37	0.18	0.18
Corneal Epithelial Cells, donor1	11526-119I5	3.29	0.00	0.44	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	1.14	4.55	0.00	0.00	0.00	3.41
Corneal Epithelial Cells, donor3	11687-122I4	5.37	1.53	0.77	0.00	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.88	12.88	4.29	1.82	2.31	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	38.48	11.04	4.42	0.95	0.95	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	0.00	3.45	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	26.57	6.37	3.02	1.73	1.62	1.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	34.51	5.12	1.37	0.68	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	28.07	4.57	1.31	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	50.33	2.90	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	2.84	0.67	0.17	0.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	1.76	0.59	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.39	0.28	0.28	0.57	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	2.36	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	2.33	0.29	0.58	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.47	0.71	0.24	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	1.93	0.35	0.18	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	4.21	0.00	0.22	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	2.13	0.00	0.91	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	5.07	0.85	1.41	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	3.27	2.08	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	1.56	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	2.98	0.85	0.71	0.00	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	4.80	1.60	0.00	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	0.52	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	4.97	0.87	0.50	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	2.17	0.87	0.87	0.43	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	4.89	0.85	0.85	0.37	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	6.83	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	3.49	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	4.40	0.94	0.31	0.00	0.16	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	49.51	0.00	1.65	0.00	1.65	1.65
Eosinophils, donor3	12246-129H5	46.37	0.00	0.00	3.57	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.38	0.24	0.98	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	51.31	52.14	2.46	8.62	2.87	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.58	0.77	0.22	0.22	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.79	2.06	0.33	0.00	0.22	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	10.07	3.27	1.70	0.12	0.12	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	15.42	2.05	0.82	0.14	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.13	7.28	1.69	0.74	0.32	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	13.96	3.95	1.84	0.00	1.05	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	7.64	2.99	0.66	0.66	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	47.63	4.99	3.63	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	10.61	0.76	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	15.14	3.00	0.79	0.79	0.79	0.16
Fibroblast - Cardiac, donor4	11452-119A3	13.34	0.00	0.30	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	6.73	3.68	1.14	0.25	0.51	0.00
Fibroblast - Cardiac, donor6	11460-119B2	6.37	2.58	1.06	0.15	0.61	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.91	1.34	0.40	0.13	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.20	1.73	0.86	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	2.93	7.32	1.46	2.93	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	4.15	0.00	1.15	0.00	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	12.04	3.39	1.36	0.34	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	4.93	1.41	0.47	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	0.94	0.47	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	5.68	3.26	0.60	0.60	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	8.82	5.31	0.79	0.68	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	11.17	5.58	0.70	0.70	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	12.67	5.85	1.62	0.00	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	3.75	1.04	0.62	0.21	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.41	0.52	1.31	0.26	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	8.17	5.14	1.84	0.40	1.19	0.13
Fibroblast - Gingival, donor3	11394-118C8	11.70	1.26	0.97	0.19	0.29	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	38.44	5.19	1.04	2.08	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	27.14	15.86	2.47	0.88	1.23	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	13.56	3.90	1.40	0.47	0.31	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	12.31	5.14	1.49	0.41	0.14	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.47	0.00	1.41	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	12.58	1.02	2.34	1.17	0.88	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.73	1.09	1.77	1.77	1.64	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.54	1.21	2.74	1.21	1.43	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	36.10	0.73	4.26	1.91	2.49	1.32
Fibroblast - Lung, donor1	11270-116H1	2.72	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	5.28	3.17	0.21	0.63	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	2.50	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	0.28	0.00	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	8.93	0.00	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	7.76	1.75	1.36	0.19	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.53	4.85	1.52	0.46	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	8.57	0.31	1.22	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.48	0.76	2.29	3.82	0.00	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.82	4.86	2.16	1.35	0.81	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	37.00	9.39	3.25	2.32	0.58	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.51	1.33	1.11	0.33	0.55	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	5.28	0.81	0.41	0.00	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	0.67	0.67	0.00	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	9.49	1.98	0.40	1.58	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	20.64	4.37	0.99	0.40	0.60	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.83	4.62	2.13	0.53	1.24	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.00	4.73	1.38	1.18	1.77	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.47	3.61	2.41	1.20	0.90	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	35.62	6.69	1.94	0.54	0.43	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	15.69	2.02	0.51	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	16.41	2.30	1.15	0.00	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	21.45	3.61	2.21	0.60	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	21.50	2.61	1.00	0.40	0.90	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.39	1.81	1.51	0.00	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.08	5.80	1.74	0.50	0.58	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	18.12	4.10	1.20	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.69	4.60	1.64	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	20.98	5.33	2.24	0.64	0.32	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	19.74	4.39	2.02	0.34	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.68	1.57	1.25	0.16	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.92	6.10	2.61	3.49	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	20.46	1.73	2.25	1.73	1.73	2.08
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.43	1.56	3.38	2.60	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	46.76	1.02	1.28	3.07	0.51	2.56
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.01	6.89	2.30	0.77	2.30	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	18.50	10.21	2.55	6.38	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.67	15.97	3.14	3.99	4.28	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	66.18	39.43	4.41	7.17	12.13	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.00	22.83	3.20	6.85	5.48	3.88
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	29.32	22.78	2.77	5.55	6.14	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	59.74	37.54	3.17	4.76	7.93	8.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	56.42	19.57	2.94	5.54	3.26	4.24
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	14.15	11.50	0.88	1.77	2.21	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.49	11.02	1.55	1.27	0.99	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	27.83	8.74	2.22	1.23	1.48	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.61	9.94	0.81	1.88	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	25.03	11.77	2.23	0.74	0.99	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	24.50	8.03	1.52	0.55	0.83	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.08	9.56	1.22	1.22	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	21.91	15.06	0.91	0.91	2.05	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	23.42	7.72	1.74	1.00	0.75	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.61	6.34	1.53	1.09	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.37	15.07	2.66	1.77	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.36	14.94	2.54	0.64	1.11	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	19.88	8.04	1.34	0.67	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.27	13.71	2.42	1.61	1.61	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	35.29	12.89	3.73	0.68	1.70	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	26.34	7.63	2.13	0.44	0.27	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.65	10.61	3.54	0.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	33.30	3.59	4.10	0.17	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	38.95	12.95	3.54	0.77	0.89	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.03	8.99	2.25	1.16	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.46	4.70	1.84	0.82	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	29.09	21.46	3.09	1.65	1.65	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	39.66	17.52	3.57	1.61	1.27	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	35.02	14.01	3.34	1.00	1.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	27.77	17.63	3.31	2.20	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	36.53	13.41	2.95	0.61	1.11	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	36.31	13.94	3.08	0.32	0.97	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	30.79	24.37	1.92	1.60	1.28	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	39.42	11.75	2.56	0.76	0.57	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.31	14.87	2.69	0.95	1.42	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.36	20.37	2.74	1.22	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	37.42	15.89	2.82	1.25	1.78	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	30.74	12.73	3.07	0.44	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.09	20.20	2.24	1.96	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.92	9.63	2.22	0.83	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	19.79	15.51	3.21	1.07	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.31	12.85	1.99	1.07	0.77	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	28.76	8.55	2.85	0.39	0.78	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.09	9.22	2.17	0.81	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.47	14.20	2.77	1.84	0.92	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.54	14.04	2.41	0.66	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	23.80	6.94	1.98	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.65	13.32	1.85	2.24	0.92	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	25.62	11.70	2.42	1.82	1.21	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	27.70	1.52	3.30	0.25	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	31.85	6.57	1.99	0.20	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	21.26	5.85	0.62	0.77	0.77	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	33.35	12.89	2.05	0.61	2.25	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.09	5.95	0.31	0.31	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	14.13	4.24	1.70	0.57	1.13	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	29.52	17.53	1.84	2.31	1.84	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	9.90	2.47	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	31.72	9.67	1.93	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	28.88	3.21	1.60	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	12.17	5.22	6.96	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.34	14.97	0.98	2.93	2.60	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	26.36	11.12	2.88	0.00	2.06	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	33.32	3.33	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.08	22.65	1.68	0.28	1.68	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	31.05	21.90	3.27	1.96	2.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	32.71	29.36	2.52	0.84	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.45	15.59	2.86	1.59	0.64	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	27.17	20.38	1.36	2.72	3.40	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	8.35	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	32.07	22.91	3.44	0.57	2.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	18.35	15.98	0.59	1.48	2.66	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	33.88	25.41	0.00	1.69	3.39	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.97	19.05	2.07	2.49	0.83	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	31.76	20.48	1.84	2.30	2.30	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	21.07	15.81	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.52	21.14	2.31	1.15	3.46	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	28.03	15.97	0.98	1.30	2.28	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	28.76	10.03	0.67	2.68	2.68	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	28.51	14.64	2.31	0.77	3.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	30.81	22.59	2.05	1.71	2.05	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	37.27	2.48	0.00	12.42	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	35.86	18.87	3.77	1.89	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	30.17	27.76	0.60	1.21	3.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.15	12.72	5.09	2.03	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	31.91	20.74	2.39	1.99	1.60	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	36.51	15.29	3.45	1.48	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	42.50	16.53	8.26	3.54	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.84	31.51	3.50	2.92	1.75	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	31.16	12.73	2.63	1.32	1.76	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	21.19	20.34	4.24	0.00	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.26	15.52	0.60	0.60	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.44	15.53	1.46	0.97	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	3.42	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	3.33	2.08	0.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.71	2.22	0.63	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.34	1.67	0.00	0.00	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.98	4.29	0.81	0.35	0.46	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.28	4.90	1.18	0.84	0.68	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	8.87	4.32	0.46	0.46	0.91	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.18	5.25	0.77	0.66	0.87	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	8.38	6.45	0.64	0.21	0.86	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.84	4.09	0.65	0.43	0.65	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.60	6.48	1.25	0.12	0.25	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	6.69	5.49	0.86	0.86	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.41	2.88	0.64	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	2.24	0.56	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.73	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	0.00	0.00	5.29	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	8.47	1.06	0.00	0.00	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.91	1.45	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.87	3.67	0.87	0.52	0.87	0.35
Hepatocyte, donor1	11523-119I2	8.47	6.05	2.42	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	6.46	5.39	1.08	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	14.72	6.14	2.45	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.96	0.00	0.65	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.93	4.54	1.75	0.00	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	15.09	5.49	1.51	0.41	0.41	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	0.00	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	0.00	3.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	0.00	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.97	0.63	0.63	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	0.00	3.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	0.00	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	5.70	0.00	3.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.46	0.00	2.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	13.66	0.00	2.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.93	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.50	0.47	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	0.91	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	0.00	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.84	0.00	1.91	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	0.00	1.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.72	0.62	1.54	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	0.00	3.51	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.74	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	2.21	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	10.46	0.00	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	13.63	5.06	1.22	0.57	0.33	0.33
Keratinocyte - epidermal, donor2	11349-117G8	4.69	0.59	1.76	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	19.22	8.14	1.70	0.47	1.04	0.57
Keratinocyte - oral, donor1	11251-116E9	34.85	3.41	3.63	0.79	1.02	0.57
Keratocytes, donor1	11527-119I6	3.44	0.00	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	16.20	2.57	1.38	0.79	0.59	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	0.00	6.59	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	2.16	7.55	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	26.99	9.00	1.85	0.00	0.81	0.12
Lens Epithelial Cells, donor3	11690-122I7	26.54	2.52	2.12	0.20	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	2.13	1.30	0.59	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	1.12	1.12	0.56	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	2.52	1.57	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	1.61	1.61	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	1.26	0.32	0.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	0.54	0.97	0.00	0.00	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	2.05	0.82	0.00	0.82	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	0.51	0.25	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	2.53	1.97	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	2.77	0.79	0.00	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	1.55	0.78	0.58	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	0.19	0.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	2.79	1.05	0.00	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	1.19	0.72	0.48	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1.51	0.69	0.27	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	1.23	2.16	0.62	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.25	1.56	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.01	0.73	0.18	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.29	1.97	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1.17	0.29	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.49	0.50	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	1.94	1.94	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	1.35	1.08	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1.36	1.36	0.30	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	1.04	1.04	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	1.47	1.88	0.00	0.00	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	0.60	0.75	0.75	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	3.44	2.06	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	1.69	0.38	0.19	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	0.64	0.42	0.00	0.00	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.39	1.45	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	0.99	1.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1.36	1.24	0.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	3.70	1.85	0.00	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	1.98	1.48	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	0.69	0.69	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	2.89	0.64	0.00	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	4.87	1.83	0.61	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	2.10	1.82	0.28	0.14	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1.78	1.78	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	0.00	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	0.62	0.31	0.00	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	2.51	1.43	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	1.96	0.98	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	0.00	0.24	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	2.35	0.99	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1.02	0.77	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	1.49	0.90	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	1.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1.48	0.74	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.23	0.42	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.11	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	2.06	0.52	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	3.17	0.23	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	3.78	1.74	0.58	0.58	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.65	2.70	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	5.28	0.00	0.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.14	3.59	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.12	2.12	0.71	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2.67	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	5.09	2.04	1.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.47	1.60	1.07	0.27	0.53	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	6.24	3.40	1.51	0.19	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.75	0.61	0.61	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	6.52	1.63	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	6.25	3.54	1.46	0.21	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	4.48	4.20	1.68	1.40	0.00	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	4.12	1.03	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	7.26	3.77	0.58	0.29	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	6.58	4.19	0.30	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	7.75	1.11	0.55	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	8.13	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	5.16	4.43	0.74	0.00	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	2.30	0.00	1.15	0.00	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	3.45	0.77	0.77	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	4.53	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	8.20	2.46	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	4.97	0.45	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	3.59	2.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.22	0.75	2.24	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	4.83	2.60	1.11	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	3.02	1.29	0.43	0.00	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	9.42	0.86	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	4.33	1.00	0.00	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	3.02	0.60	1.81	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.27	0.00	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	5.16	1.37	0.69	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1.61	1.61	2.15	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	3.37	1.35	0.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	5.19	1.11	1.11	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	6.80	1.60	1.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	3.63	0.00	2.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	1.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1.97	0.49	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1.88	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.54	2.51	1.01	0.50	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	3.60	0.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.23	1.34	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	5.47	1.56	1.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	4.62	1.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6.75	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	5.25	1.31	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.59	1.12	1.12	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	6.62	1.32	1.32	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	3.86	2.31	0.77	0.00	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	1.52	0.51	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.61	2.88	0.96	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	4.37	1.59	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	4.86	1.22	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.84	0.69	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	6.08	1.90	1.52	0.38	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.16	1.55	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	6.65	0.95	0.00	0.00	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	2.67	0.53	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	3.45	1.15	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	5.66	2.06	1.03	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	2.83	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	3.97	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	7.07	1.25	0.83	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.13	0.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	3.76	1.67	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.97	1.39	0.46	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	2.68	1.34	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	4.81	1.07	1.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	5.66	1.21	0.40	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	4.59	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.98	1.14	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	0.77	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.02	1.64	1.09	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	5.35	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	4.16	0.26	0.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	8.62	1.33	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	73.62	10.94	7.98	3.42	2.28	0.91
Macrophage - monocyte derived, donor2	11313-117C8	44.59	8.44	2.57	1.10	0.73	0.55
Macrophage - monocyte derived, donor3	11389-118C3	64.10	12.32	5.77	4.19	1.44	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	21.24	3.72	0.00	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	45.63	0.16	5.55	1.27	1.90	0.95
Mallassez-derived cells, donor3	11930-125I4	33.50	6.53	3.47	0.69	1.11	0.83
Mammary Epithelial Cell, donor1	11273-116H4	9.57	5.58	2.49	0.40	0.90	0.10
Mammary Epithelial Cell, donor2	11350-117G9	7.82	4.05	0.87	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.48	0.75	1.00	0.00	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	15.59	0.68	6.10	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	25.52	4.76	3.14	0.76	0.22	0.11
Mast cell, donor2	11565-120D8	38.93	3.27	4.75	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	26.56	1.80	4.73	0.45	0.00	0.00
Mast cell, donor4	11567-120E1	41.13	8.16	5.67	0.53	1.06	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	12.53	1.89	2.22	0.55	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	3.50	2.33	0.58	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	21.22	3.90	6.31	0.92	0.46	0.23
Mast cell, expanded, donor8	11941-126A6	13.39	3.35	3.01	0.33	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	3.28	0.50	0.40	0.30	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	5.54	2.42	0.35	0.00	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	29.99	5.07	1.88	0.29	0.72	0.58
Melanocyte - light, donor1	11274-116H5	10.58	1.18	0.47	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	6.14	0.68	2.05	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	1.73	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	16.45	6.77	1.67	1.25	0.73	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	19.09	13.45	1.61	1.34	1.61	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	29.20	11.25	3.48	2.68	0.80	0.54
Meningeal Cells, donor1	11493-119E8	19.48	0.37	1.12	0.00	0.00	0.12
Meningeal Cells, donor2	11573-120E7	15.41	1.76	1.76	0.44	0.44	1.76
Meningeal Cells, donor3	11654-122E7	20.54	3.75	3.26	0.49	1.30	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.70	1.43	0.57	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	18.11	8.25	1.41	1.11	0.50	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.74	6.46	2.87	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.16	1.48	0.64	0.21	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	3.02	5.03	0.50	1.51	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	3.08	0.22	0.44	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	0.73	0.00	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2.46	0.41	0.82	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.85	2.35	0.83	0.14	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.35	1.49	0.37	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.05	8.68	2.76	0.79	1.32	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.08	0.59	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	2.34	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.04	1.28	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	13.47	3.90	1.77	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	33.46	7.51	4.07	0.63	1.25	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	8.71	0.73	1.45	2.18	1.45
Mesothelial Cells, donor1	11247-116E5	9.55	3.18	0.80	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	9.01	2.00	0.00	1.00	1.00	1.00
Mesothelial Cells, donor3	11402-118D7	16.84	8.38	1.01	1.73	0.51	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	43.21	1.35	8.10	1.35	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	53.93	33.25	3.94	8.37	1.48	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.04	11.19	1.18	1.47	2.06	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	46.18	17.67	2.79	6.20	2.79	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.44	12.24	2.28	1.24	1.24	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	4.63	9.26	6.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	54.81	29.78	4.00	5.76	2.75	2.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	34.91	12.10	2.33	3.26	0.93	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	46.74	20.52	3.45	5.69	3.66	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.13	9.11	3.17	1.98	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	17.10	8.55	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	27.43	14.16	4.42	1.77	0.88	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.58	17.86	1.52	0.00	1.52	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	22.37	2.63	0.00	5.26	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.04	17.83	1.70	5.52	1.06	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	21.18	0.92	2.76	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	21.46	15.80	2.38	5.66	2.09	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	30.18	0.00	3.35	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	18.07	12.29	0.25	2.51	1.00	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	18.30	9.03	1.90	1.66	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	6.08	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.43	7.14	0.69	1.61	0.46	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	14.09	2.94	1.26	0.63	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.64	3.26	0.82	0.41	0.00	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.52	9.44	0.86	1.93	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.78	2.89	1.56	0.89	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.57	2.63	1.75	1.53	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.62	1.01	1.01	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	2.45	0.82	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.18	1.47	0.88	1.18	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	0.00	1.09	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.81	0.96	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.00	2.40	1.60	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	5.48	1.37	4.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	5.01	1.50	2.50	1.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.44	3.50	0.00	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.73	0.00	0.64	1.28	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	8.18	3.72	1.24	1.49	0.50	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	0.00	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	6.63	17.68	2.21	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.04	8.21	1.71	0.68	1.03	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.44	0.44	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	18.11	1.42	1.78	1.07	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.19	8.42	0.84	1.12	1.12	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.90	1.25	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	19.81	0.58	1.75	4.08	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.38	5.73	1.81	2.11	0.60	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.10	3.34	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	21.66	0.00	21.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	5.54	2.77	1.85	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	8.54	2.85	0.57	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.57	1.11	0.97	1.24	0.00	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.18	5.44	2.85	1.30	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	1.29	0.86	3.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	0.00	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.41	2.14	0.80	2.94	0.80	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.67	3.89	1.50	1.20	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.58	1.41	2.40	1.41	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.92	5.73	2.55	0.64	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	15.70	2.65	1.77	1.55	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.24	0.76	1.90	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	12.78	5.97	1.99	0.28	0.28	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	14.01	7.13	1.23	0.98	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	18.90	4.56	1.96	3.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.94	6.47	1.18	3.23	1.18	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.32	6.92	2.02	2.02	0.86	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.78	6.18	2.47	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.51	2.98	1.49	2.38	0.30	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	41.44	60.27	3.77	15.07	18.83	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	17.82	3.56	7.13	3.56	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	53.56	37.13	4.27	7.89	4.60	3.29
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	42.08	34.71	2.10	4.21	7.36	6.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	45.47	25.90	4.74	3.36	2.37	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	58.67	15.83	2.79	8.38	2.79	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	35.30	41.31	3.38	6.38	4.13	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	32.23	17.05	2.40	3.46	1.60	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	53.27	10.29	4.75	1.36	3.05	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	22.84	26.52	1.47	0.74	0.74	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	56.06	31.88	4.03	7.69	2.20	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	32.67	87.11	0.00	14.00	7.78	10.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.02	0.53	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	39.39	20.20	1.01	8.08	1.01	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.07	5.90	1.26	2.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	0.00	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.45	4.52	2.59	0.86	0.65	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.77	15.16	3.14	2.61	1.57	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	2.00	2.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.26	1.25	0.00	2.09	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.61	1.90	0.95	0.19	0.19	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	0.00	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.04	1.36	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	1.67	0.42	0.42	1.67	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.42	1.39	0.00	0.23	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2.70	0.81	0.27	2.16	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.99	3.15	1.05	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	33.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	0.99	0.50	0.50	1.49	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.68	1.35	1.35	0.81	0.54	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	3.63	2.27	0.23	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.21	1.14	0.49	1.96	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	11.12	5.83	0.91	1.64	0.91	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.77	2.65	0.00	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	3.00	1.80	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.56	2.63	1.64	1.97	0.98	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.69	1.79	0.16	0.65	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.82	7.23	1.06	2.47	0.53	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	2.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.57	3.22	0.92	1.38	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.68	3.53	0.64	1.61	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.59	6.21	0.69	1.03	1.38	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	10.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	19.61	6.68	2.23	2.90	0.22	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.35	2.12	0.42	0.42	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.12	1.42	0.95	1.66	0.47	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.87	2.58	0.86	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	54.17	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.00	1.33	0.67	1.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.13	4.51	1.80	6.76	0.00	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	1.98	0.00	3.17	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	2.79	0.00	3.71	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.92	1.89	0.76	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.78	2.93	0.00	1.63	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	0.44	0.00	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.35	9.05	3.17	6.78	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	1.76	0.88	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	2.66	3.99	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	6.94	1.49	0.99	0.50	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	5.36	1.15	3.83	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.40	0.91	1.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.23	8.62	2.21	3.76	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	4.74	0.68	3.39	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.90	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.81	4.09	0.63	1.89	0.00	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.66	0.91	0.30	1.21	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	7.12	0.00	2.37	0.79	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	10.20	1.13	1.13	6.80	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	7.33	3.11	0.87	0.50	0.12	0.12
Myoblast, donor2	11322-117D8	7.29	3.07	0.96	0.96	0.38	0.19
Myoblast, donor3	11398-118D3	26.23	4.54	2.19	0.84	0.00	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	47.28	34.73	2.48	3.50	1.02	1.17
Natural Killer Cells, donor1	11230-116C6	32.29	4.92	1.23	0.92	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	30.76	21.71	0.90	1.81	0.90	0.90
Natural Killer Cells, donor3	11387-118C1	29.45	13.25	2.58	2.58	1.66	1.10
Neural stem cells, donor1	11275-116H6	22.50	4.72	2.18	0.00	0.36	0.00
Neural stem cells, donor2	11352-117H2	32.74	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	14.79	13.65	3.41	0.00	0.00	0.00
Neurons, donor2	11574-120E8	23.78	6.60	5.72	0.66	0.66	0.22
Neurons, donor3	11655-122E8	26.31	12.33	5.76	0.82	1.64	0.00
Neutrophils, donor1	11233-116C9	52.90	12.99	1.86	2.78	3.71	1.86
Neutrophils, donor2	11314-117C9	40.58	14.49	2.90	8.70	0.00	2.90
Neutrophils, donor3	11390-118C4	135.00	2.44	5.50	0.61	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	9.62	1.78	0.83	0.12	0.36	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	4.23	0.65	0.65	0.65	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	15.64	2.61	0.20	0.80	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	21.89	20.10	1.24	2.89	1.65	2.06
Olfactory epithelial cells, donor2	11934-125I8	36.91	31.12	2.17	6.08	4.05	2.75
Olfactory epithelial cells, donor3	11935-125I9	34.16	28.83	2.04	5.33	2.72	1.93
Olfactory epithelial cells, donor4	11936-126A1	28.05	13.54	1.66	1.66	1.46	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	18.05	3.61	1.81	0.60	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	8.30	1.28	1.06	0.43	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	8.00	1.14	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	11.17	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.08	1.76	0.59	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	25.28	10.53	2.81	0.70	1.40	0.00
Osteoblast, donor3	11426-118G4	28.26	3.20	1.24	1.07	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	18.87	4.30	1.94	0.25	0.84	0.17
Pericytes, donor1	11491-119E6	1.78	0.33	0.22	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	6.11	0.91	0.45	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	5.49	3.05	1.02	0.20	0.20	0.20
Perineurial Cells, donor1	11499-119F5	20.34	6.22	1.58	0.79	0.57	0.45
Perineurial Cells, donor2	11579-120F4	8.37	0.46	1.01	0.09	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	22.95	2.87	1.59	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.92	8.82	1.22	1.96	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	27.95	5.18	1.42	1.42	0.52	0.26
Placental Epithelial Cells, donor1	11278-116H9	5.50	0.72	0.72	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	21.07	1.11	0.00	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	18.26	2.55	0.98	0.39	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.92	1.90	0.63	0.00	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	8.63	5.25	1.88	0.19	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	11.49	3.52	1.04	0.78	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	14.86	4.95	0.90	0.45	0.90	0.23
Preadipocyte - omental, donor1	11468-119C1	16.09	7.25	1.07	0.96	0.43	0.32
Preadipocyte - omental, donor2	11329-117E6	18.33	6.11	0.44	1.31	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	42.83	16.04	1.00	3.87	2.72	2.29
Preadipocyte - perirenal, donor1	11469-119C2	14.76	4.92	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	8.29	0.31	0.61	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	15.94	13.81	2.48	0.53	1.06	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	11.92	5.45	0.68	0.51	0.34	0.34
Preadipocyte - visceral, donor1	11280-116I2	12.67	6.43	1.58	0.37	0.28	0.09
Preadipocyte - visceral, donor2	11357-117H7	13.35	15.19	1.38	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	9.61	5.96	1.25	0.52	0.52	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.27	3.77	1.36	0.45	0.75	0.30
Prostate Epithelial Cells, donor2	11331-117E8	22.48	15.44	1.22	1.49	0.81	0.81
Prostate Epithelial Cells, donor3	11404-118D9	13.29	6.67	1.47	0.73	0.61	0.31
Prostate Stromal Cells, donor1	11254-116F3	15.72	2.73	1.82	0.46	0.80	0.23
Prostate Stromal Cells, donor2	11332-117E9	12.55	8.79	1.43	0.18	1.43	0.18
Prostate Stromal Cells, donor3	11405-118E1	15.64	7.61	1.15	0.73	0.63	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.11	1.09	1.09	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.85	8.39	3.26	0.55	0.83	0.49
Renal Epithelial Cells, donor1	11517-119H5	5.58	0.00	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.85	2.85	0.71	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	44.04	18.10	5.72	1.91	2.01	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	1.21	0.81	0.27	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	27.97	10.88	4.00	2.66	4.66	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	4.84	1.54	0.88	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	8.78	3.13	0.63	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.22	0.83	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	4.83	1.88	0.81	0.54	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.11	1.27	1.27	0.00	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	5.21	2.31	0.58	0.19	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	8.04	5.96	1.30	0.00	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	0.85	0.85	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.02	1.76	1.25	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	33.14	11.36	3.61	1.07	0.67	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.08	0.89	0.89	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.05	5.50	4.40	2.20	3.30	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	4.06	0.00	3.48	4.06	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.64	3.90	2.60	0.39	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	13.31	6.26	1.89	0.79	0.40	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	12.60	3.01	2.79	0.33	0.33	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	13.77	4.34	2.60	0.12	0.62	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	13.40	6.53	1.86	0.82	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	12.25	5.32	1.39	0.23	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	15.06	4.38	1.78	0.55	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.92	3.78	2.42	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	17.74	1.43	2.87	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	13.34	4.59	1.43	0.43	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	10.19	5.58	1.50	0.11	0.54	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	15.71	7.30	1.77	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.53	3.82	0.96	1.15	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.93	5.40	1.86	1.30	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	9.21	3.76	2.07	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	17.52	3.98	1.73	0.40	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	12.65	3.89	1.75	1.07	0.19	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	10.31	8.40	2.29	0.38	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	15.59	2.67	1.60	0.43	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.30	4.48	3.08	0.28	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	16.06	5.64	2.73	0.85	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	16.59	3.10	1.09	1.28	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	10.79	6.50	2.82	0.61	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	12.76	5.10	2.96	0.40	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	15.80	3.54	1.65	0.24	0.94	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	12.90	7.54	2.38	0.40	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	17.30	5.38	3.74	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	18.66	7.26	1.24	0.41	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.72	6.19	2.88	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	17.76	9.40	2.51	1.46	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	18.03	4.44	2.15	1.08	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	16.52	6.47	3.24	1.19	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.23	10.80	1.54	0.96	0.77	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	15.65	4.64	1.38	0.69	0.69	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	16.05	4.12	3.02	0.96	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	12.81	6.24	2.46	0.82	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	12.27	2.73	0.85	1.19	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	16.72	6.21	2.22	0.59	1.04	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	17.86	5.06	2.13	0.80	0.27	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.45	3.46	1.66	0.41	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.19	6.43	3.10	0.48	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	17.94	6.85	2.42	3.83	0.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	17.42	3.01	1.60	0.38	0.57	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	14.32	4.19	2.79	0.35	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.55	4.23	2.42	0.60	1.21	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	16.40	4.28	1.22	0.49	0.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	30.42	6.99	5.39	0.44	0.58	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	16.43	5.48	3.65	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	16.58	3.92	2.11	0.30	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	20.81	8.60	3.17	0.23	0.23	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	22.17	8.69	3.00	1.50	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	20.43	3.31	2.48	0.35	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	20.28	5.98	2.99	1.28	0.21	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.03	8.41	4.21	1.80	0.00	0.00
Schwann Cells, donor1	11498-119F4	6.39	0.56	0.38	0.19	0.19	0.19
Schwann Cells, donor2	11578-120F3	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	17.31	5.70	1.10	1.75	1.10	0.44
Sebocyte, donor1	11220-116B5	32.87	3.83	1.10	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	18.84	8.27	1.38	0.46	0.92	0.46
Sebocyte, donor3	11378-118B1	7.01	2.06	1.24	0.21	0.21	0.21
Sertoli Cells, donor1	11255-116F4	48.04	18.22	6.63	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	56.49	87.56	8.47	11.30	8.47	8.47
Skeletal Muscle Cells, donor1	11281-116I3	15.48	5.98	1.94	0.62	0.44	0.44
Skeletal Muscle Cells, donor2	11358-117H8	7.23	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	1.67	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	8.33	5.66	1.41	0.31	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	9.22	5.80	1.19	0.74	0.89	0.00
Skeletal Muscle Cells, donor6	11459-119B1	12.62	4.77	2.77	0.46	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	8.32	3.40	1.13	0.25	0.76	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	10.13	2.43	1.00	0.86	0.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	14.29	3.77	2.08	0.79	1.19	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.56	5.14	1.60	0.34	0.42	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	2.17	2.17	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.78	2.20	0.69	0.14	0.00	0.14
Skin - palm, donor1	10286-104F7	40.29	2.69	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	28.25	6.20	2.16	1.44	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	21.27	6.54	1.64	1.64	3.27	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	13.50	2.08	1.56	0.39	0.65	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	19.60	7.37	2.78	0.56	0.83	1.67
Small Airway Epithelial Cells, donor2	11334-117F2	43.60	25.46	3.24	3.94	0.56	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	57.30	13.11	4.86	1.27	1.69	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	23.08	7.20	2.62	3.45	0.82	1.57
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.95	1.54	0.00	0.62	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.45	3.78	4.45	0.44	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.05	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.54	0.22	0.88	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.76	0.39	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.91	1.55	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	11.01	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.12	0.80	0.67	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.62	8.87	1.77	1.55	1.33	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	13.70	3.84	1.15	0.90	0.26	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	17.91	3.58	3.58	1.30	1.63	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	43.71	4.43	2.66	0.59	0.89	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	53.81	9.54	4.13	2.42	1.99	1.99
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.63	0.49	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.44	3.04	0.91	0.00	0.91	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7.58	0.00	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.54	1.91	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.73	5.75	2.51	0.74	1.18	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	32.93	17.00	2.58	0.86	1.51	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.49	7.77	3.46	1.78	1.57	1.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2.94	0.62	0.15	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1.08	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6.87	1.79	0.60	0.30	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.46	0.34	0.00	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.95	6.05	2.43	0.39	1.10	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.23	1.71	1.11	0.00	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	4.55	3.41	0.46	0.00	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	1.81	0.60	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	11.66	1.59	1.06	0.26	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.91	5.46	1.07	0.13	0.53	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.93	13.77	1.88	1.75	1.75	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.10	1.52	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	11.16	1.96	0.45	0.00	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.00	6.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	1.29	3.88	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.23	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.06	3.03	0.00	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.40	5.33	0.94	0.00	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.88	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	8.50	1.42	0.67	0.25	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.88	1.87	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.76	1.87	0.72	0.43	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.39	1.53	0.76	0.51	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.58	2.63	0.19	0.38	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.70	6.15	2.52	0.28	0.84	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	79.85	20.44	5.11	0.59	2.01	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	0.48	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.54	2.20	0.24	0.49	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.99	6.63	1.55	0.44	0.44	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	7.90	2.63	0.88	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.97	2.14	0.97	0.39	1.55	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.73	1.59	0.79	1.59	1.32	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.23	1.12	1.49	1.12	1.12	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.11	3.23	0.36	1.08	1.44	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	5.39	0.28	0.85	0.00	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	3.54	3.15	1.18	0.00	2.36	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	7.36	1.52	0.51	1.52	1.27	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	12.78	3.59	0.80	1.60	1.20	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	9.61	8.78	0.84	1.67	1.67	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	9.17	3.67	0.92	0.46	1.38	1.38
Synoviocyte, donor1	11291-117A4	28.28	14.81	3.87	1.35	2.19	1.18
Synoviocyte, donor2	11368-117I9	40.40	22.80	3.69	2.68	1.68	1.68
Synoviocyte, donor3	11440-118H9	55.41	30.61	2.46	2.23	1.56	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	3.22	0.71	0.71	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.40	0.46	0.23	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.46	5.16	1.51	0.43	0.14	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	7.34	0.00	0.00	0.39	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	10.31	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	38.38	11.32	3.69	0.98	0.49	0.37
Urethra, donor2	10319-105A4	28.77	21.58	3.60	14.39	0.00	1.80
Urothelial Cells, donor1	11520-119H8	13.02	3.19	1.06	0.53	0.80	0.53
Urothelial Cells, donor2	11600-120H7	4.01	5.21	1.20	0.80	0.80	0.40
Urothelial Cells, donor3	11681-122H7	5.04	2.29	0.69	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	58.62	19.39	7.13	1.34	2.23	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	41.82	8.01	1.78	1.78	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	55.75	12.87	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.86	13.01	2.05	1.37	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.65	0.69	2.07	1.38	1.72	2.41
Whole blood (ribopure), donor090325, donation2	12177-128I8	24.40	2.32	1.16	2.32	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	46.86	16.66	3.12	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	36.71	11.01	1.84	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	24.65	7.30	2.74	0.00	1.83	1.83
Wilms' tumor cell line:G-401	10809-111A8	9.87	5.30	1.60	0.86	0.62	0.25
Wilms' tumor cell line:HFWT	10597-108E3	37.84	0.00	3.52	7.04	0.88	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.33	11.45	0.56	0.84	0.00	0.84
achilles tendon, donor2	10292-104G4	20.67	16.53	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	14.02	4.33	0.00	1.27	1.02	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	6.27	2.32	1.16	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	15.31	0.59	0.71	0.00	0.12	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.97	5.99	2.72	1.09	0.82	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	19.96	10.40	0.00	0.28	1.41	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	27.70	4.02	3.17	1.69	2.54	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	9.26	10.34	1.09	1.91	1.36	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	8.81	0.88	0.88	2.64	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.83	5.31	3.27	2.04	3.68	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	34.95	3.88	2.33	3.11	3.49	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.67	7.18	1.47	0.92	0.37	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	11.70	3.90	11.70	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	12.08	8.60	2.32	1.63	0.70	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	4.92	6.21	1.04	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	4.68	4.09	0.88	0.29	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	9.30	2.79	1.39	2.32	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	22.62	24.26	2.88	0.82	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	28.55	3.99	2.46	3.99	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	27.74	8.53	2.99	0.85	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	24.26	9.71	3.34	0.61	0.61	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	25.03	8.91	5.05	0.48	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	23.61	20.05	1.34	4.01	2.23	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.01	10.67	1.33	5.34	1.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	0.00	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.07	5.65	2.64	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	19.19	10.03	3.49	3.49	0.87	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	15.00	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	14.60	0.71	1.18	1.65	0.94	0.47
adipose tissue, adult, pool1	10010-101C1	17.22	1.71	1.40	0.00	0.16	0.00
adipose, donor1	10184-103D4	102.04	83.86	6.45	2.93	9.38	9.97
adipose, donor2	10185-103D5	48.26	57.99	4.06	13.79	6.08	6.08
adipose, donor3	10186-103D6	56.64	32.40	3.81	8.44	5.17	5.17
adipose, donor4	10187-103D7	65.87	13.87	5.20	6.93	4.33	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	5.68	5.05	3.47	0.63	0.32	0.16
adrenal gland, adult, pool1	10081-102A9	7.28	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	10.54	2.93	3.47	0.40	0.27	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	11.79	18.58	2.14	0.36	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	33.85	6.96	2.32	1.16	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	31.11	7.10	2.70	1.69	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	26.51	5.01	1.47	1.47	0.29	0.00
amygdala - adult, donor10196	10167-103B5	24.90	3.56	0.00	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	23.12	7.71	2.84	0.41	0.61	0.20
amygdala, newborn, donor10223	10360-105E9	2.58	2.26	0.65	0.65	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	37.43	5.86	4.20	1.15	1.15	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1.76	0.88	0.66	0.44	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	52.78	31.73	3.34	5.68	2.34	1.67
aorta, adult, pool1	10052-101G7	60.02	31.97	3.92	5.69	0.98	1.37
appendix, adult	10189-103D9	23.68	7.76	3.10	3.10	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.94	8.25	2.06	0.34	1.72	0.00
artery, adult	10190-103E1	8.15	12.23	0.00	0.00	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	41.00	1.88	2.17	1.30	2.17	1.74
b cell line:RPMI1788	10427-106D4	3.72	0.89	1.49	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	30.24	9.43	1.94	0.55	0.55	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	6.55	2.98	1.19	0.00	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	6.36	2.85	0.84	0.67	0.50	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	14.54	16.78	0.56	0.00	0.56	1.12
bladder, adult, pool1	10011-101C2	20.75	3.80	2.17	0.76	0.33	0.54
blood, adult, pool1	10053-101G8	31.00	11.07	0.00	6.64	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	1.71	3.43	0.86	0.00	0.00
bone marrow, adult	10192-103E3	19.57	2.02	2.70	1.35	1.35	0.67
brain, adult, donor1	10084-102B3	8.20	3.08	1.03	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	18.15	4.12	1.22	0.45	0.22	0.56
brain, fetal, pool1	10085-102B4	26.71	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	15.86	5.95	0.66	4.29	0.66	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	5.62	2.37	0.87	0.12	0.12	0.12
breast, adult, donor1	10080-102A8	20.83	8.84	1.26	1.26	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.51	1.27	0.38	0.89	0.51	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	10.20	15.15	1.86	2.47	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	7.37	15.89	3.91	0.69	1.84	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.46	22.03	0.24	4.60	0.48	0.97
carcinoid cell line:NCI-H1770	10703-109H1	22.57	30.56	2.82	3.76	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	9.08	1.42	0.88	0.22	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	10.46	15.53	0.95	3.49	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	34.87	11.45	3.19	3.19	3.19	1.86
caudate nucleus - adult, donor10196	10177-103C6	11.51	3.45	3.45	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	16.23	3.51	1.67	0.50	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	3.82	1.53	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	4.03	3.66	0.37	1.46	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	32.05	17.48	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	38.22	6.19	4.48	0.64	0.21	0.00
cerebellum, adult, pool1	10083-102B2	12.07	10.00	2.76	0.69	0.34	1.03
cerebellum, newborn, donor10223	10357-105E6	6.64	1.66	0.83	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	8.07	4.29	0.50	0.50	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	8.77	6.58	1.46	6.58	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	9.35	2.01	0.58	0.14	0.58	0.00
cervical cancer cell line:ME-180	10553-107I4	47.56	16.41	2.98	1.82	2.15	0.66
cervix, adult, pool1	10013-101C4	26.67	6.19	3.15	0.94	0.21	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	261.68	72.73	11.01	11.84	9.75	5.29
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	9.94	2.98	0.75	1.12	0.25	0.00
choriocarcinoma cell line:SCH	10785-110H2	7.02	3.33	0.37	0.49	0.99	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	8.06	0.71	0.24	0.71	0.71	0.47
chorionic membrane cells, donor1	12238-129G6	51.57	10.26	4.56	0.85	1.42	0.57
chorionic membrane cells, donor2	12239-129G7	29.73	4.28	1.39	0.99	0.70	0.10
chorionic membrane cells, donor3	12240-129G8	60.99	14.84	6.59	3.30	4.95	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	9.09	2.02	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	31.70	13.83	1.54	0.38	0.19	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	13.09	2.96	0.84	0.63	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	15.15	7.45	2.82	1.54	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	14.03	11.61	2.42	3.14	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.32	8.14	1.63	1.22	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	26.80	13.25	3.83	2.36	1.77	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	17.20	0.52	1.30	0.52	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	3.89	3.89	0.91	0.23	0.69	0.23
clear cell carcinoma cell line:TEN	10636-108I6	3.47	0.17	0.52	0.17	0.00	0.35
colon carcinoma cell line:CACO-2	10513-107D9	12.08	4.76	0.73	0.55	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	20.52	4.56	3.04	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	28.56	19.04	3.57	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	23.50	4.58	2.00	0.59	0.24	0.35
colon, fetal, donor1	10070-101I7	16.69	17.30	0.62	7.42	1.24	1.85
common myeloid progenitor CMP, donor1	12130-128D6	50.42	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	19.97	13.60	3.40	1.27	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	12.38	9.51	2.41	0.60	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	16.22	10.72	2.68	0.85	0.85	0.56
corpus callosum, adult, pool1	10042-101F6	26.65	2.65	2.76	0.11	0.33	0.00
cruciate ligament, donor2	10295-104G7	21.88	6.48	3.24	3.24	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	17.66	16.85	1.61	2.41	0.80	0.00
diencephalon, adult	10193-103E4	11.04	4.32	0.96	0.48	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	8.27	6.20	0.69	0.23	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.59	2.05	1.28	1.28	0.77	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	4.81	4.33	1.69	0.48	0.00	0.00
ductus deferens, adult	10196-103E7	10.47	9.47	1.00	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	23.04	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	21.33	11.03	0.74	0.74	2.21	0.00
dura mater, adult, donor1	10041-101F5	57.23	5.04	4.71	0.50	0.41	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	12.66	5.77	1.11	0.22	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	5.30	4.44	0.57	0.43	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	14.80	4.93	1.23	3.70	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	6.96	2.72	1.51	1.21	0.91	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.51	1.85	1.85	2.78	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	21.02	2.63	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.05	0.67	0.00	1.68	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	16.67	6.16	3.08	1.63	2.72	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.91	1.61	0.96	0.80	0.80	0.64
epidermoid carcinoma cell line:A431	10426-106D3	7.89	2.00	1.00	0.78	0.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	23.10	3.74	2.86	0.44	0.33	0.11
epididymis, adult	10197-103E8	14.23	4.40	2.09	1.05	0.84	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	8.69	0.71	0.89	1.77	1.24	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2.36	1.18	0.79	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	18.35	8.39	2.23	0.66	0.13	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	18.31	7.18	0.98	0.59	0.89	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	18.93	8.40	1.34	0.45	0.67	0.22
esophagus, adult, pool1	10015-101C6	20.92	3.19	2.02	0.11	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	4.01	0.25	1.00	0.00	0.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	28.97	12.07	0.00	9.66	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	10.52	10.52	2.10	10.52	2.10	2.10
eye - muscle medial, donor2	10299-104H2	13.39	4.46	0.00	16.37	0.00	1.49
eye - muscle superior, donor2	10297-104G9	18.34	5.73	1.15	9.17	1.15	3.44
eye - vitreous humor, donor1	10268-104D7	16.03	8.74	0.00	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	23.64	7.12	2.54	2.80	0.25	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	17.69	10.13	1.41	0.77	0.77	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	3.56	3.80	0.71	1.66	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	9.57	1.22	0.94	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.51	11.41	2.10	2.10	0.00	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	15.73	5.85	4.94	1.01	0.27	0.18
gall bladder, adult	10198-103E9	20.52	9.42	0.97	1.21	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	53.69	12.35	0.54	3.22	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	44.07	21.29	3.73	1.49	2.99	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.43	8.03	1.90	0.63	0.84	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	8.12	2.51	0.39	0.19	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	18.53	7.71	2.30	1.64	0.49	0.82
gastric cancer cell line:GSS	10560-108A2	7.32	2.75	3.66	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	7.54	3.88	1.60	0.23	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	5.05	2.07	1.26	0.23	0.34	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	7.28	0.28	1.26	0.42	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	11.97	1.50	1.50	4.99	1.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.07	2.96	1.37	0.53	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	10.39	4.21	1.12	1.54	0.28	1.26
glioblastoma cell line:T98G	10485-107A8	5.63	2.54	1.21	0.77	0.00	0.11
glioma cell line:GI-1	10413-106B8	10.25	1.17	0.88	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	16.76	2.19	0.00	0.00	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	42.47	17.09	3.91	1.22	0.98	1.46
globus pallidus, adult, donor10258	10367-105F7	9.58	5.48	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	9.06	0.53	0.00	1.07	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	0.00	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.48	7.68	1.60	2.88	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	13.77	0.46	1.38	1.38	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	16.00	1.37	0.46	0.46	0.46	0.91
hIPS +CCl2, biol_rep3	14385-156C2	13.53	1.93	0.64	0.00	1.29	1.29
hIPS, biol_rep1	14380-156B6	7.19	0.00	1.44	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	11.66	0.00	0.69	0.69	2.74	0.69
hIPS, biol_rep3	14382-156B8	8.83	1.10	3.31	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	12.93	15.52	3.16	1.15	1.15	0.00
heart - mitral valve, adult	10205-103F7	22.12	8.97	2.69	3.89	0.60	0.90
heart - pulmonic valve, adult	10206-103F8	22.49	6.28	1.31	3.14	1.83	0.26
heart - tricuspid valve, adult	10207-103F9	15.82	12.49	2.50	4.16	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	22.24	4.29	2.04	4.29	1.84	1.43
heart, adult, diseased, donor1	10051-101G6	9.79	5.54	0.43	0.43	0.43	0.43
heart, adult, pool1	10016-101C7	11.73	3.91	1.84	0.46	0.00	0.69
heart, fetal, pool1	10046-101G1	22.90	2.36	2.77	0.31	0.00	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	66.33	53.37	3.09	11.11	2.78	1.85
hepatoblastoma cell line:HuH-6	10633-108I3	32.11	1.19	2.38	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	14.36	7.40	1.66	1.44	0.22	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	17.24	7.28	2.79	0.61	0.24	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	13.24	4.75	2.43	0.30	0.20	0.30
hepatoma cell line:Li-7	10484-107A7	6.56	1.33	0.67	0.11	0.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	6.53	2.81	0.90	0.40	0.10	0.30
hippocampus - adult, donor10196	10169-103B7	10.41	8.52	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	21.63	8.57	1.02	0.00	0.82	0.82
hippocampus, adult, donor10258	10374-105G5	3.49	1.49	1.00	0.00	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	1.76	0.70	0.70	0.00	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	22.58	10.99	2.44	1.22	3.05	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	15.12	17.08	2.16	0.98	2.36	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	11.43	6.60	1.78	1.52	3.30	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.22	15.79	1.69	3.38	2.82	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	46.99	20.40	4.39	2.32	2.07	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	34.54	15.56	2.66	1.52	3.80	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	30.07	14.89	3.50	3.50	1.46	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	39.85	14.22	2.37	3.02	1.94	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	23.77	12.10	2.50	5.42	4.17	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	57.07	11.13	2.84	2.84	1.66	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	53.20	32.14	2.09	5.79	1.93	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	56.56	16.16	3.37	3.37	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	13.46	10.02	0.63	0.78	1.25	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.77	7.37	1.97	0.98	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	5.24	8.73	1.75	2.62	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	80.95	39.52	6.49	3.82	3.63	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	76.75	44.92	5.23	4.80	5.67	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	60.97	32.48	10.00	6.50	7.50	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	45.03	20.53	3.58	2.26	2.83	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	46.38	34.10	5.91	5.91	4.55	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.50	22.55	5.01	4.70	7.52	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	49.81	43.76	3.92	3.43	3.43	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	59.51	29.03	5.23	4.64	5.23	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	33.48	27.80	4.18	3.59	4.48	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.96	11.27	0.74	0.55	0.74	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	17.40	9.13	0.86	1.14	2.57	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	13.88	10.62	1.22	2.04	6.12	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	46.47	12.67	4.93	3.52	1.06	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.66	21.22	4.12	3.48	4.75	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	35.71	16.64	6.96	3.03	3.63	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.13	17.58	2.59	2.59	3.10	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	39.85	15.94	5.31	3.98	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.14	9.49	2.31	1.80	3.33	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	55.48	21.73	2.05	4.60	2.30	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	48.46	35.59	3.03	5.30	0.76	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	42.34	29.57	2.02	9.75	6.39	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	18.84	11.35	1.21	1.21	0.72	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.91	7.58	2.23	0.45	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.73	7.80	1.46	0.98	1.95	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	49.82	14.98	5.50	1.83	3.36	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	65.06	45.55	9.76	9.76	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.07	14.56	3.97	3.97	5.30	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	41.59	15.32	3.28	1.09	3.28	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	35.10	7.60	5.43	3.26	3.62	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	24.20	8.90	2.85	3.20	3.20	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	32.22	25.06	1.19	1.19	4.77	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	61.35	9.21	3.93	1.63	2.03	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.14	27.21	3.50	4.58	5.39	3.23
immature langerhans cells, donor1	11904-125F5	35.84	1.70	4.12	1.21	0.48	1.21
immature langerhans cells, donor2	11905-125F6	21.39	3.96	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	9.84	0.57	1.14	0.09	0.19	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	26.66	4.88	1.63	0.33	0.98	0.65
kidney, adult, pool1	10017-101C8	22.33	5.41	1.50	0.90	0.50	0.00
kidney, fetal, pool1	10045-101F9	19.38	0.99	2.33	0.21	0.14	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	18.04	0.57	2.27	1.56	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.18	13.69	1.52	1.24	0.83	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	11.74	6.97	0.73	1.83	0.18	0.55
left atrium, adult, donor1	10079-102A7	12.53	11.44	0.54	0.54	1.63	0.54
left ventricle, adult, donor1	10078-102A6	7.58	5.06	1.01	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	12.31	6.84	0.55	2.19	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	2.16	0.72	0.00	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	3.26	2.72	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	4.61	1.94	0.73	0.49	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	14.64	3.14	2.09	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.74	9.21	1.65	1.65	0.47	1.18
liposarcoma cell line:KMLS-1	10782-110G8	9.84	0.16	1.56	0.16	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	38.14	10.84	5.73	5.36	1.58	1.95
liver, adult, pool1	10018-101C9	11.67	0.97	1.13	0.32	0.00	0.00
liver, fetal, pool1	10086-102B5	14.11	3.76	0.00	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	11.23	6.42	1.02	1.17	1.02	0.44
locus coeruleus, adult, donor10252	10165-103B3	28.79	14.21	1.29	0.92	0.92	0.00
locus coeruleus, adult, donor10258	10375-105G6	10.44	6.21	0.56	1.97	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	4.21	5.89	0.42	0.84	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	7.47	2.08	0.42	0.97	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	4.83	0.69	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	5.67	2.77	1.32	0.79	0.40	0.13
lung, adult, pool1	10019-101D1	25.16	3.43	1.42	0.95	0.35	0.12
lung, fetal, donor1	10068-101I5	27.97	2.85	4.28	0.00	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	42.16	20.62	1.83	4.58	0.46	3.21
lymph node, adult, donor1	10077-102A5	26.98	11.83	0.95	0.47	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	3.95	1.32	0.44	0.44	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	14.34	3.92	0.30	0.91	0.30	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	13.59	16.14	1.70	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	13.32	0.44	0.89	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	19.30	1.87	2.08	0.62	0.83	0.62
mature adipocyte, donor3	12233-129G1	13.99	1.19	1.90	0.95	0.95	0.47
mature adipocyte, donor4	12234-129G2	12.11	1.05	1.58	0.00	0.00	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	12.63	0.00	2.38	0.48	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	10.15	1.13	2.26	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	17.84	5.33	1.29	0.37	0.74	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	6.04	3.49	1.27	1.91	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	3.41	0.00	1.71	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	4.05	1.35	1.18	0.17	0.51	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	21.01	6.58	1.06	0.42	0.42	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	1.79	1.79	1.44	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	17.52	7.79	0.65	2.60	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	36.53	9.60	3.56	0.93	1.08	0.77
medulla oblongata, adult, pool1	10038-101F2	26.28	3.43	1.88	0.24	0.41	0.16
medulla oblongata, newborn, donor10223	10361-105F1	6.60	4.17	1.39	0.69	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	20.15	6.42	3.76	0.22	1.33	0.66
medulloblastoma cell line:ONS-76	10759-110E3	11.62	0.61	2.20	1.83	0.61	0.49
melanoma cell line:COLO 679	10514-107E1	22.42	11.50	1.87	1.29	1.58	0.86
melanoma cell line:G-361	10465-106H6	34.20	10.04	5.43	0.81	1.09	1.09
meningioma cell line:HKBMM	10691-109F7	6.15	3.26	1.63	1.45	0.90	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	44.06	9.69	6.17	1.76	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	46.14	9.59	5.44	1.56	1.56	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.35	3.07	0.46	0.15	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.72	2.91	1.27	0.00	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.97	1.66	0.83	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.43	1.26	0.42	0.14	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.79	1.54	1.16	0.00	0.58	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.16	1.39	0.00	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.72	2.57	1.37	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.24	1.73	0.58	0.58	0.58	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.98	2.52	1.86	0.00	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	13.77	3.24	0.95	0.00	0.41	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	16.22	2.28	0.85	0.43	0.85	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	15.81	3.95	2.31	1.32	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.52	4.84	1.38	0.83	0.55	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	6.63	4.54	0.00	1.75	0.00	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.50	2.04	1.43	0.20	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.78	5.39	2.16	1.08	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	39.93	8.59	3.00	0.62	1.45	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.68	5.93	1.37	1.37	0.91	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	22.24	4.20	0.84	1.26	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.66	5.98	1.79	0.45	1.34	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	16.19	3.15	2.01	0.26	0.53	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.89	5.89	0.74	0.00	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	8.87	5.72	1.72	0.29	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	12.63	9.68	2.53	0.84	3.79	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.76	2.28	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.42	3.58	0.77	0.51	0.00	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.42	3.93	0.52	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	3.70	6.47	0.92	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.53	1.65	0.00	0.47	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	4.74	6.43	1.35	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.07	7.07	0.39	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.95	3.71	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.36	1.15	0.29	0.29	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.03	2.68	0.89	0.00	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	9.37	2.88	0.72	0.24	0.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	7.33	0.00	1.47	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.72	2.01	1.01	0.34	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.91	2.46	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.87	2.58	0.43	0.43	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	8.20	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33	5.16	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.52	3.57	0.32	1.30	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	10.18	0.00	2.91	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.13	10.13	1.07	1.60	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	3.27	7.36	0.82	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	4.66	3.50	1.17	0.78	0.78	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	4.20	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	9.93	1.99	5.96	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.93	5.34	1.19	0.59	1.78	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	3.66	1.22	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.70	4.43	0.00	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.83	2.07	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	4.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	0.41	0.00	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	4.77	0.79	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.36	2.95	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	0.94	0.31	0.31	0.94	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	2.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	2.37	0.00	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	2.07	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	1.98	0.99	0.99	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	0.00	1.12	3.36	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	2.54	0.64	0.64	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.45	2.01	0.40	0.00	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.89	1.82	0.00	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	4.52	0.00	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	6.59	0.82	2.47	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.93	4.17	0.79	0.20	0.60	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.09	5.84	0.00	2.60	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	4.07	2.04	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	29.40	0.00	4.64	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	6.85	0.94	2.60	0.94	0.24	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	4.40	3.01	0.70	0.70	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	8.55	4.27	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.78	0.51	1.34	0.31	0.21	0.21
mesothelioma cell line:Mero-25	10850-111F4	4.09	1.59	0.68	0.91	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	3.67	3.18	0.73	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	3.32	1.77	1.33	0.89	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	4.47	3.15	2.10	0.53	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	5.45	2.21	0.17	0.51	0.17	0.68
mesothelioma cell line:Mero-84	10855-111F9	4.30	2.27	0.76	0.25	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	12.42	7.66	2.28	1.86	1.04	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	10.60	8.61	2.82	0.17	0.99	0.50
mesothelioma cell line:NCI-H226	10846-111E9	6.15	4.34	0.54	0.54	0.54	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	1.37	2.05	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	6.87	6.62	1.02	1.53	0.51	0.25
mesothelioma cell line:No36	10857-111G2	8.48	4.89	1.30	0.65	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	4.88	4.06	0.27	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	5.76	0.77	1.54	0.19	0.38	0.58
migratory langerhans cells, donor2	11902-125F3	9.65	1.83	2.81	1.10	0.00	0.37
migratory langerhans cells, donor3	11903-125F4	10.95	2.51	1.79	0.00	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	28.73	16.32	3.26	3.59	1.63	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.08	1.48	0.64	3.81	1.91	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.44	0.00	0.92	1.15	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.75	4.57	1.33	1.14	0.76	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	19.59	8.13	2.03	1.29	0.37	0.37
myeloma cell line:PCM6	10474-106I6	13.84	4.15	2.37	1.78	0.20	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.89	1.52	4.06	8.62	1.01	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	36.68	9.22	2.75	2.55	0.78	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	14.82	4.01	1.56	0.22	0.56	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.96	3.31	2.65	0.37	0.37	0.15
nasal epithelial cells, donor2	12227-129F4	20.98	1.66	2.21	1.10	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	85.35	27.61	6.21	7.59	1.84	2.07
neuroblastoma cell line:NB-1	10539-107G8	13.84	0.75	0.75	0.94	0.56	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	9.91	0.21	0.63	0.42	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	30.93	10.81	1.30	1.68	1.68	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	2.85	1.66	0.24	0.47	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	5.07	1.11	0.16	0.63	0.00	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	8.25	1.01	0.81	1.01	0.60	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.09	0.00	0.00	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	37.53	17.57	1.86	4.26	0.53	1.60
neutrophil PMN, donor1	12133-128D9	178.50	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	159.37	39.84	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	18.60	1.01	2.88	0.17	0.34	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	7.20	0.80	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	37.51	22.12	2.24	1.92	0.96	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.41	10.51	0.53	0.26	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	13.12	1.12	1.12	0.00	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	8.24	2.06	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	31.13	12.34	2.42	1.07	1.34	0.81
occipital cortex, newborn, donor10223	10355-105E4	3.64	0.73	1.46	0.36	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	3.67	9.97	0.52	0.52	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	29.18	24.46	4.29	4.72	0.86	0.43
occipital pole, adult, pool1	10036-101E9	6.31	0.47	0.71	0.16	0.00	0.00
olfactory region, adult	10195-103E6	8.02	1.91	0.76	0.19	0.19	0.00
optic nerve, donor1	10277-104E7	16.01	4.00	0.00	10.01	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	11.16	1.14	1.37	0.11	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.76	0.55	2.06	0.69	0.69	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	17.61	4.23	1.69	4.06	0.68	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	12.24	2.66	1.27	0.35	0.23	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	69.08	18.23	2.94	5.59	3.23	2.94
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	4.67	5.61	2.80	0.00	4.67
osteosarcoma cell line:HS-Os-1	10558-107I9	12.72	1.27	0.85	1.27	0.42	0.64
ovary, adult, pool1	10020-101D2	21.75	1.83	2.62	0.26	0.00	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.80	13.57	1.47	8.07	0.37	2.02
pancreas, adult, donor1	10049-101G4	12.23	4.70	1.88	2.82	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	9.78	9.22	0.84	0.28	0.56	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	14.82	11.07	0.85	0.34	0.51	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	13.08	2.65	1.66	0.50	0.00	0.50
paracentral gyrus, adult, pool1	10035-101E8	11.35	1.10	1.46	0.18	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	6.61	0.73	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	12.23	1.88	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	15.96	5.70	1.43	0.29	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	8.81	0.44	1.06	0.00	0.09	0.18
parietal lobe, fetal, donor1	10072-101I9	42.67	6.79	4.85	2.91	1.94	3.88
parietal lobe, newborn, donor10223	10356-105E5	3.36	1.12	0.00	0.37	0.00	0.00
parotid gland, adult	10199-103F1	11.72	4.32	0.00	1.23	0.62	0.62
penis, adult	10200-103F2	21.48	5.91	4.30	2.15	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.19	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	7.72	5.83	0.44	0.87	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	9.68	4.52	0.00	1.29	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	29.61	5.92	1.18	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	8.78	4.39	0.63	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	24.28	14.17	3.04	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	47.95	9.38	3.65	1.04	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	23.83	6.81	3.40	2.55	0.00	0.85
placenta, adult, pool1	10021-101D3	82.13	15.27	6.24	2.69	1.08	0.97
plasma cell leukemia cell line:ARH-77	10840-111E3	12.18	6.49	2.25	0.53	0.66	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	41.71	10.74	1.40	2.80	0.78	0.78
pons, adult, pool1	10033-101E6	22.72	3.44	1.98	0.34	0.34	0.00
postcentral gyrus, adult, pool1	10032-101E5	5.58	0.87	1.05	0.17	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	31.37	0.00	12.55	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.47	5.68	1.75	0.73	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	7.44	2.54	0.54	1.27	0.54	0.00
prostate, adult, pool1	10022-101D4	22.22	3.17	1.81	0.45	0.27	0.18
putamen, adult, donor10196	10176-103C5	9.91	4.25	1.18	1.18	0.00	0.24
putamen, adult, donor10252	10152-102I8	15.69	3.92	1.96	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	3.28	0.00	0.00	1.09	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	7.25	0.48	0.00	0.24	0.24	0.00
putamen, newborn, donor10223	10365-105F5	1.50	3.75	2.25	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	5.53	2.04	0.58	0.87	0.00	0.29
rectum, fetal, donor1	10067-101I4	48.68	20.86	2.78	6.95	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	4.66	1.91	0.64	0.00	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.53	7.04	4.14	0.41	1.66	0.83
retina, adult, pool1	10030-101E3	23.76	2.58	1.79	0.40	0.00	0.20
retinoblastoma cell line:Y79	10475-106I7	29.62	10.39	2.60	1.30	0.78	2.60
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.98	0.49	0.25	0.12	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	38.24	18.84	1.69	5.06	0.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	37.89	6.06	2.27	3.79	2.27	0.00
salivary acinar cells, donor1	11771-123I7	12.79	8.42	1.29	0.81	0.49	0.32
salivary acinar cells, donor2	11772-123I8	10.46	4.68	1.24	0.55	0.28	0.28
salivary acinar cells, donor3	11773-123I9	18.54	3.31	2.65	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	12.01	1.14	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.77	0.34	1.35	0.51	0.42	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.23	0.59	1.88	0.59	0.94	0.59
seminal vesicle, adult	10201-103F3	17.46	8.47	2.12	2.65	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	13.12	2.92	0.24	0.97	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.79	3.27	0.75	0.50	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	5.02	4.01	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.24	0.81	2.15	1.07	1.75	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	12.93	4.20	1.11	0.44	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.52	0.77	0.13	0.13	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	2.84	2.13	3.55	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	13.07	3.12	0.96	0.60	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	13.07	5.03	3.02	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	0.00	27.14	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	30.30	11.36	5.05	3.79	0.00	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	118.07	31.35	3.00	6.67	4.34	3.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	33.41	9.14	2.52	2.52	1.58	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	9.83	3.85	4.63	0.00	0.58	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	55.71	18.13	1.81	3.13	1.15	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	23.00	16.08	3.54	1.13	1.29	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	24.62	0.44	2.18	2.18	1.31	1.31
small intestine, adult, pool1	10024-101D6	20.66	4.90	1.67	0.36	0.48	0.48
small intestine, fetal, donor1	10064-101I1	17.69	12.28	0.98	3.69	1.72	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	1.54	0.00	0.51	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	42.90	12.15	3.62	3.10	1.29	0.78
somatostatinoma cell line:QGP-1	10781-110G7	16.35	0.54	1.61	4.82	0.27	0.80
spinal cord - adult, donor10196	10181-103D1	17.43	5.28	1.15	0.23	0.69	0.23
spinal cord, adult, donor10252	10159-103A6	45.34	11.04	2.76	1.18	0.79	1.18
spinal cord, adult, donor10258	10369-105F9	6.23	2.08	1.38	0.69	3.46	0.00
spinal cord, fetal, donor1	10056-101H2	32.93	10.98	3.05	1.83	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	8.27	2.76	3.67	0.46	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	34.35	13.74	2.09	3.29	0.60	1.79
spleen, adult, pool1	10025-101D7	23.24	4.19	2.20	0.66	0.11	0.11
spleen, fetal, pool1	10044-101F8	22.64	0.79	2.38	0.24	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	7.87	1.86	2.17	0.00	0.31	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.19	0.95	1.71	4.37	1.71	2.47
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	29.35	4.19	3.49	6.64	3.49	3.49
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.97	3.13	2.35	8.21	1.95	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	2.36	0.23	0.56	0.45	0.11	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	2.54	0.85	0.00	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	7.62	0.00	0.85	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	69.42	10.68	3.20	13.88	2.14	1.07
submaxillary gland, adult	10202-103F4	10.82	9.68	1.14	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	651.29	0.00	54.27	217.10	54.27
substantia nigra, adult, donor10252	10158-103A5	35.31	15.37	2.28	1.45	0.83	0.62
substantia nigra, adult, donor10258	10371-105G2	7.76	0.52	0.52	2.07	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	4.24	12.01	0.71	3.53	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	13.07	1.60	3.21	2.52	1.15	0.69
temporal lobe, adult, pool1	10031-101E4	6.78	1.10	1.19	0.00	0.00	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	22.79	20.66	4.27	2.85	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	16.26	6.59	3.08	3.96	0.44	0.44
tenocyte, donor1	11763-123H8	39.45	16.41	3.84	3.49	2.79	0.70
tenocyte, donor2	11765-123I1	52.65	28.99	3.82	4.20	6.49	3.43
tenocyte, donor3	11768-123I4	28.91	16.31	2.22	2.97	1.48	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.41	13.26	0.85	0.51	0.51	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	26.36	6.94	1.85	3.24	1.08	1.85
teratocarcinoma cell line:PA-1	10807-111A6	28.05	8.99	1.86	1.55	0.46	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	19.55	1.65	1.14	2.54	1.78	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	9.08	1.89	0.38	2.27	1.13	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	22.25	3.38	0.76	0.55	0.33	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	31.27	22.80	1.63	4.56	2.93	3.26
testis, adult, pool1	10026-101D8	17.29	2.79	2.36	0.75	0.21	0.00
testis, adult, pool2	10096-102C6	13.98	8.12	3.16	1.35	2.26	0.90
thalamus - adult, donor10196	10168-103B6	25.39	17.66	3.31	6.62	1.10	0.00
thalamus, adult, donor10252	10154-103A1	29.22	12.19	2.19	0.94	0.31	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	0.00	1.54	1.54	7.70	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.07	3.62	0.82	1.15	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	4.03	9.21	0.00	1.73	1.73	0.00
throat, adult	10209-103G2	13.23	4.49	1.50	0.75	0.00	0.25
throat, fetal, donor1	10061-101H7	21.63	4.27	1.52	3.35	1.22	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	4.57	2.38	1.99	0.79	0.20	0.00
thymus, adult, pool1	10027-101D9	19.39	0.50	2.78	0.10	0.00	0.00
thymus, fetal, pool1	10043-101F7	25.25	1.87	1.56	0.10	0.21	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.96	9.31	2.53	1.46	1.20	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	12.71	1.12	0.70	2.37	0.42	1.12
thyroid, adult, pool1	10028-101E1	13.81	1.12	0.93	0.09	0.19	0.00
thyroid, fetal, donor1	10060-101H6	23.73	15.29	1.85	3.43	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	6.16	0.00	12.32	0.00	0.00
tongue, adult	10203-103F5	12.79	1.86	0.93	0.23	0.00	0.00
tongue, fetal, donor1	10059-101H5	28.37	8.67	0.39	5.12	0.00	1.58
tonsil, adult, pool1	10047-101G2	23.74	1.50	3.11	0.40	0.00	0.10
trachea, adult, pool1	10029-101E2	20.04	3.35	2.94	0.74	0.08	0.00
trachea, fetal, donor1	10058-101H4	35.78	10.39	2.31	3.85	1.54	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	18.78	18.07	2.48	3.19	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	10.33	3.24	1.32	0.20	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	12.22	0.78	2.82	0.94	0.63	1.57
tridermal teratoma cell line:HGRT	10694-109G1	93.22	3.81	7.61	20.93	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	11.34	3.30	0.42	0.51	0.08	0.25
umbilical cord, fetal, donor1	10057-101H3	58.42	31.30	4.17	2.09	6.26	8.35
uterus, adult, pool1	10100-102D1	35.32	6.83	3.24	0.51	0.34	0.00
uterus, fetal, donor1	10055-101H1	38.91	31.23	3.07	6.14	1.54	1.02
vagina, adult	10204-103F6	10.99	2.58	2.58	0.65	0.00	0.00
vein, adult	10191-103E2	15.56	10.96	2.85	1.53	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.94	1.34	1.07	0.27	0.27	0.53